EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
AXIS Capital Holdings Limited
AXS

AXS AXIS Capital Holdings Limited

AXIS Capital Holdings Limited · NYSE
Market Closed
98.24
▼ ⁦-0.66%⁩ (-0.65)
Market Cap$7.2B
Beta0.51
52w Low52w High
88.07119.99
Last Week
⁦-1.43%⁩
Last Month
⁦-3.49%⁩
Last 3 Months
⁦+3.49%⁩
Last Year
⁦-0.15%⁩
EL7 Factor Analysis
How we score this
Overall75
Strong — clearly above market medianContrarianF 5/9Better than 75% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
93
6.2x▲17.8xTop tier
▸
Growth
59
9.1%▲7.1%Around median
▸
Quality
92
——Top tier
▸
Safety
24
——Bottom tier
▸
Capital Return
24
1.79%▼2.12%Bottom tier
▸
Momentum
48
6.7%▲2.9%Around median
▸
Sentiment
76
7▲3Top tier
Fair Value
Low confidenceCurrent price$98
Analyst target · 2 analysts
$124
⁦+26%⁩
See it clearly undervalued
Range ⁦$108–$130⁩
vs
DCF (estimate)
N/A (negative FCF)

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener
Premium content

Get Your Premium Account Now

  • Stock Deep Analysis
  • The Advanced News Platform
Recommended
Annual plan
$17/mo
Monthly plan
$29/mo

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target· 2 analysts setting price target
$121.50
⁦+23.7%⁩
Current Price $98.24·Median $124.00
Low
$108.00
High
$130.00
Current price
$98.24
Average target
$121.50
Street summary

Stable Targets Despite Fewer Analysts

Price target expectations have not changed over the past 30 days; the consensus average remained at 121.5, while the median is 124, and the range is between 108 and 130 versus a current price of 98.61. However, the number of analysts used in the snapshots declined from 5 to 2, reducing the sample breadth and increasing uncertainty around the strength of the consensus, despite the targets remaining above the current price.

As of 2026-09-08
Revisions momentum · 30d
⁦0.0%⁩
Average rating
★ 3.83
Buy
Analyst coverage
12
Buy conviction
67%
High
Target dispersion
22%
Analyst ratings over time12 analysts rating
2
6
4
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months3.83 → 3.83
Recent analyst moves
  • = Reiterate2026-08-03
    UBS
    Buy
  • = Reiterate2026-07-29
    BMO Capital
    Market Perform
  • = Reiterate2026-07-08
    UBS
    Buy
Premium content
Key Financials

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.

StockSector medianSector averagetypical sector range
MetricValuePosition within sectorVerdict
  • P/E (TTM)
    6.19x
    3.16x25.26x
    Very cheap
  • Forward P/E
    7.02x
    2.76x22.06x
    Very cheap
  • EV / EBITDA
    —
    —
  • FCF Yield
    —
    —
  • Revenue Growth YoY
    9.1%
    -36.3%104.2%
    Near median
  • EPS Growth YoY
    51.9%
    -99.4%194.2%
    Above average
  • Gross Margin
    —
    —
  • ROIC
    —
    —
  • Net Debt / EBITDA
    —
    —
  • Dividend Yield
    1.8%
    0.6%9.0%
    Low
  • Payout Ratio
    11.1%
    9.8%97.8%
    Low
  • Altman Z-Score
    —
    —
Financial Analysis
|

Stock Analysis

AI-generated
Based on 2026-07-29 data

Company Overview

AXIS Capital Holdings Limited operates through two principal platforms, Insurance and Reinsurance, with a focus on specialty risks and short-tail policies. The company generates revenue from insurance and reinsurance premiums, as well as investment income and fees associated with AXIS Capacity Solutions, known as ACS, and insurance-linked securities investments. In Q2 FY2026, gross written premiums reached $2.7 billion, including $2.2 billion in Insurance and $440 million in Reinsurance, while short-tail business represented 57% of group premiums.

In Q2 FY2026, gross written premiums increased 6% year over year, as 15% Insurance growth offset a 25% contraction in Reinsurance premiums. The company reported net income available to common shareholders of $251 million, or $3.38 per diluted share, and operating income of $211 million, or $2.84 per diluted share. Annualized return on equity was 17%, annualized operating return on equity was approximately 14%, and diluted book value per share increased 15% year over year for the fifteenth consecutive quarter.

The group's combined ratio was 93.1% in Q2 FY2026, with a current-year combined ratio excluding catastrophes of 89% and a general and administrative expense ratio of 10.9%. The Insurance segment generated underwriting income of $119 million, a combined ratio of 90%, and a combined ratio excluding catastrophes of 84.5%, compared with a Reinsurance combined ratio of 94.5%. EDGAR data for Q1 FY2026 shows revenue of $1.6 billion, net income of $254.8 million, and earnings per share of $3.29, while revenue for the twelve-month period ended FY2026 was approximately $6.7 billion and net income was $1.1 billion.

What's Driving the Stock

  • The Insurance segment is driving growth, with gross written premiums increasing 15% to $2.2 billion in Q2 FY2026; approximately 8 percentage points of growth came from ACS, approximately 5 points from expanded classes, and approximately 2 points from the core portfolio.
Earnings callEDGAR filings30-day newsInsider activity

Automated analysis for informational purposes only — not investment advice.

  • The property business expanded 21% overall with significant support from ACS, but AXIS reduced its net property exposure by 15% and increased the cession rate under its property reinsurance treaty from 30% to 37% at the mid-FY2026 renewals, while maintaining catastrophe protection that attaches at $100 million per event.
  • ACS provides a growing source of fees while keeping net underwriting appetite under control; ACS fee income approached $4 million in Q2 FY2026, and management expects it to reach approximately $17 million for the full FY2026.
  • Insurance submission flow in the North American wholesale channel reached 20%, and wholesale accounted for 68% of Insurance premiums in the region, compared with approximately 19% for retail and 13% for delegated business. Liability also grew 8% with a 7% rate increase, while professional lines grew 16% with a 2% rate increase, supported by E&O and classes such as Allied Health and Design Pro.
  • Investment income reached $182 million in Q2 FY2026, while fixed-maturity investment income increased 9%, supported by cash flows and a higher portfolio yield. The company returned $122 million to shareholders, split between $33 million in dividends and $89 million in share repurchases, with $263 million remaining under the existing authorization.
  • Buying & Selling Case

    ▲ Buying Case4 pts

    • +AXIS combines premium growth with underwriting profitability; gross written premiums increased 6% in Q2 FY2026, and the combined ratio remained below 100% at 93.1%, while Insurance delivered a 90% combined ratio and underwriting income of $119 million.
    • +The portfolio has become more oriented toward specialty short-tail business, which represented 57% of premiums in Q2 FY2026, alongside selective reductions in professional and liability lines in Reinsurance. AXIS Re recorded its tenth consecutive profitable quarter despite reducing premiums by 25%.
    • +Capital demonstrated strong growth and returns, with diluted book value per share increasing 15% year over year for the fifteenth consecutive quarter, annualized return on equity of 17%, and annualized operating return on equity of approximately 14% in Q2 FY2026.
    • +Fees and investments support earnings diversification beyond underwriting; total fee income reached $22 million in Q2 FY2026, while investment income was $182 million, and management expects ACS to contribute approximately $17 million in fees during FY2026.

    ▼ Selling Case6 pts

    • −AXIS faces broad-based rate declines and competition; property rates fell 17% in Q2 FY2026, with the decline in E&S property reaching approximately 22%, while cyber insurance rates fell 7% and the company reduced its cyber premiums by 5% during the quarter and 30% across the group.
    • −Pricing and mix pressure has begun to affect loss metrics, as the Insurance underlying loss ratio increased 1.7 percentage points to 54% in Q2 FY2026. Management stated that the quarter's level represents a guidepost for the remainder of FY2026, with the potential for further increases if rate reductions accelerate.
    • −Reinsurance premiums contracted 25% in Q2 FY2026, with professional lines accounting for 58% of the reduction and liability for 42%, while the decline was 10% during the first half. Management also indicated that potential volume from the RAC Re agreement may fall below its previous expectations as it reassesses the units AXIS will continue to support.
    • −North American Insurance channels are notably concentrated in wholesale, which represented 68% of the region's premiums in Q2 FY2026, compared with 19% for retail and 13% for delegated business. This mix makes growth results more dependent on continued strength in wholesale submission flow, which reached 20% during the quarter.
    • −Catastrophe losses reached $80 million, or 5.3% of premiums, in Q2 FY2026; they included $49 million from severe convective storms and $31 million from the conflict with Iran. Management explained that the Middle East situation remains fluid, while convective storms have become more frequent, more geographically widespread, and more costly per event.
    • −Analyst targets range from $108 to $130, a $22 spread that reflects materially different assessments of earnings and risk. The lowest target also falls within the 52-week range of $88.07 to $119.99, so the Buy consensus does not eliminate repricing risk if declining rates lead to further increases in loss ratios.

    Valuation

    The analyst consensus rates AXS a “Buy,” with an average target of $121.5 and a range of $108 to $130; the average is slightly above the 52-week high of $119.99, while the highest target exceeds it by approximately $10. The data does not include a usable earnings multiple, so the earnings anchor is FY2025 earnings per share of $12.35 and $14.23 for the twelve-month period ended FY2026, while improved earnings and book value must be weighed against declining property rates and a higher underlying loss ratio.

    BuyAnalyst target: $121.5(+23.7%)

    Figures in the text are as of 2026-08-30; the live price is shown at the top of the page.

    FAQ

    What drove AXS's results in Q2 FY2026?

    Gross written premiums increased 6% to $2.7 billion, driven by a 15% increase in Insurance premiums to $2.2 billion. The company generated net income available to common shareholders of $251 million and diluted earnings of $3.38 per share, in addition to operating income of $211 million. The group recorded a combined ratio of 93.1%, while annualized return on equity reached 17% and annualized operating return on equity was approximately 14%.

    Why did AXIS reduce its Reinsurance business?

    AXIS reduced Reinsurance premiums by 25% in Q2 FY2026 because of greater discipline in liability and professional lines. Professional lines represented 58% of the decline, while liability represented 42%, due to management's assessment of ceding commissions, loss-development risk, and pricing. Despite the contraction, the segment generated $440 million in premiums and a 94.5% combined ratio, and remained profitable for the tenth consecutive quarter.

    How important is AXIS Capacity Solutions to AXS shares?

    ACS enables the company to write larger gross limits in selected classes while using third-party capital and preserving its net underwriting appetite. ACS contributed approximately 8 percentage points of Insurance segment growth in Q2 FY2026, and its fee income reached nearly $4 million. Management expects ACS fees to reach approximately $17 million for the full FY2026, within total fee income of $22 million for the quarter.

    How do declining insurance rates affect AXIS's margins?

    Property rates fell 17% in Q2 FY2026, with the decline in E&S property reaching 22%, while cyber insurance rates declined 7%. AXIS responded by increasing loss estimates, which pushed the Insurance underlying loss ratio to 54%, up 1.7 percentage points year over year. It also reduced its net property portfolio by 15% and increased cessions from 30% to 37%, while maintaining catastrophe protection with an attachment point of $100 million per event.

    How large is AXS's exposure to catastrophes and the conflict in the Middle East?

    AXIS recorded catastrophe losses of $80 million in Q2 FY2026, equivalent to a catastrophe loss ratio of 5.3%. The losses included $49 million from severe convective storms in the United States and $31 million from the conflict with Iran, particularly in terrorism and marine war coverages. Management said weather losses were within its modeled expectations, but described the Middle East situation as fluid and continues to monitor exposures.

    What does the analyst consensus say about AXS's valuation?

    The analyst consensus is “Buy,” with an average price target of $121.5, a high target of $130, and a low target of $108. The average is slightly above the 52-week range high of $119.99, but the $22 spread between the high and low reflects clear uncertainty. The upside is linked to 15% growth in diluted book value per share and return on equity, while the cautious view is linked to declining property rates and a higher underlying loss ratio.